These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15866098)

  • 1. Impairment of cardiac function in a successful full-term pregnancy in a homozygous beta-thalassemia major: does chelation have a positive role?
    Tsironi M; Ladis V; Margellis Z; Deftereos S; Kattamis Ch; Aessopos A
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):117-8. PubMed ID: 15866098
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of beta-thalassemia.
    Lerner N
    Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z; Fischer R; Treadwell M; Yamashita R; Fung EB; Calvelli L; Quirolo K; Foote D; Harmatz P; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():486-91. PubMed ID: 16339703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and lactation in homozygous beta-thalassemia major.
    Surbek DV; Glanzmann R; Nars PW; Holzgreve W
    J Perinat Med; 1998; 26(3):240-3. PubMed ID: 9773387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron chelating in thalassaemia with left ventricular dysfunction.
    Cagirci G; Tufekcioglu O; Yetim M
    Heart; 2006 Oct; 92(10):1440. PubMed ID: 16973798
    [No Abstract]   [Full Text] [Related]  

  • 8. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of multiple right atrial masses in a child with beta thalassaemia and receiving desferioxamine.
    West M; Malik GA; Pollock JC
    Heart; 2003 May; 89(5):501. PubMed ID: 12695451
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A; Italia S; Campisi S
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron chelation.
    Hershko C; Link G; Pinson A
    Prog Clin Biol Res; 1989; 309():133-40. PubMed ID: 2675082
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life and life expectancy in thalassemic patients with complications.
    Gabutti V; Piga A; Sacchetti L; Sandri A; Biginelli M; Saracco P; Ferri M
    Prog Clin Biol Res; 1989; 309():35-41. PubMed ID: 2780748
    [No Abstract]   [Full Text] [Related]  

  • 13. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassaemia major: the murky story of deferiprone.
    Savulescu J
    BMJ; 2004 Feb; 328(7436):358-9. PubMed ID: 14962851
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iron chelators].
    Villegas A
    Med Clin (Barc); 1994 May; 102(19):739-41. PubMed ID: 8041203
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
    Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience.
    Jethani J; Marwah K; ; Patel S; Shah B
    Indian J Ophthalmol; 2010; 58(5):451-2. PubMed ID: 20689215
    [No Abstract]   [Full Text] [Related]  

  • 20. Fertility in thalassemia: the Greek experience.
    Karagiorga-Lagana M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():945-51. PubMed ID: 10091169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.